Nuveen Large Cap Gr Idx Retire (TRIRX)

Nasdaq Currently unchanged in today's trading session

1 member of Congress has disclosed 1 trade in Nuveen Large Cap Gr Idx Retire (TRIRX) via STOCK Act filings. The most recent disclosure was a sale by Ralph Norman on 15 December 2018. Aggregate disclosed activity totals roughly $32.5K in sales (midpoint estimates from bracketed disclosure amounts).

Nuveen Large Cap Gr Idx Retire is currently trading at $80.28, positioned at 81% of its 52-week range ($66.66 – $83.51).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$80.28
24h Change
0.00 (0.00%)
52 Week Range
$66.66$83.51
View on NASDAQ

Nuveen Large Cap Gr Idx Retire Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for TRIRX

Select to highlight on chart
1 transactions
Compliance: 0%
Ralph Norman15 Dec 201813 Aug 2018SaleStock$15,001 - $50,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$19.83B

Volume

0

Beta

1.20

P/E Ratio

4.90

Fundamentals

EPS

$16.39

Div. Yield

3.97%

Open

$80.28

Day Range

$80.28 – $80.28

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2002-09-06

Under typical market conditions, this fund dedicates at least 80% of its total assets to securities comprising its benchmark, the Russell 1000® Growth Index. While not acquiring every single stock, it generally purchases most companies represented wi...

No earnings data available for this stock.

Dividends

Dividend History

12 Dec 2025
Amount $3.1843
6 Dec 2024
Amount $2.0263
8 Dec 2023
Amount $0.8726
9 Dec 2022
Amount $3.9569
10 Dec 2021
Amount $4.9209
11 Dec 2020
Amount $0.8381
6 Dec 2019
Amount $0.7799
7 Dec 2018
Amount $1.0163
8 Dec 2017
Amount $0.4855
9 Dec 2016
Amount $0.2477
11 Dec 2015
Amount $0.5464
12 Dec 2014
Amount $0.5834
13 Dec 2013
Amount $0.2735
7 Dec 2012
Amount $0.2337
9 Dec 2011
Amount $0.1562
10 Dec 2010
Amount $0.1266
11 Dec 2009
Amount $0.1252
12 Dec 2008
Amount $0.1129
14 Dec 2007
Amount $0.1900
22 Dec 2006
Amount $0.2680
23 Dec 2005
Amount $0.1230
29 Dec 2004
Amount $0.3388
29 Dec 2003
Amount $2.0578
27 Dec 2002
Amount $0.0387

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about TRIRX

Which members of Congress have traded TRIRX?
1 member of Congress has disclosed 1 trade in Nuveen Large Cap Gr Idx Retire (TRIRX) under the STOCK Act: Ralph Norman.
When was TRIRX most recently disclosed by Congress?
The most recent TRIRX disclosure was a sale by Ralph Norman on 15 December 2018.
What is the total disclosed congressional trading volume for TRIRX?
Members of Congress have disclosed approximately $32.5K in TRIRX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in TRIRX?
This TRIRX page updates as soon as new STOCK Act disclosures are filed for Nuveen Large Cap Gr Idx Retire. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.